The Incidence of HIV drug resistance and its impact on progression of HIV disease among antiretroviral-naïve participants started on three different antiretroviral therapy strategies.

Kozal, Michael J; Hullsiek, Katherine Huppler; Macarthur, Rodger D; Berg-Wolf, Mary van den; Peng, Grace; Xiang, Ying; Baxter, John D; Uy, Jonathan; Telzak, Edward E; Novak, Richard M

Kozal, Michael J; Hullsiek, Katherine Huppler; Macarthur, Rodger D; Berg-Wolf, Mary van den; Peng, Grace; Xiang, Ying; Baxter, John D; Uy, Jonathan; Telzak, Edward E; Novak, Richard M.

Affiliation

Kozal MJ; Yale University School of Medicine and VA CT Healthcare System, New Haven, Connecticut 06510, USA. Michael.Kozal@yale.edu

HIV Clin Trials ; 8(6): 357-70, 2007.

Article in En | MEDLINE | ID: mdl-18042501

Subject(s)

Anti-HIV Agents/therapeutic use; Drug Resistance, Viral/genetics; HIV Infections/drug therapy; HIV Infections/virology; HIV/genetics; Antiretroviral Therapy, Highly Active; Disease Progression; HIV Infections/mortality; Humans; Incidence; Patient Compliance; Risk Factors; Time Factors; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV / Anti-HIV Agents / Drug Resistance, Viral Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: HIV Clin Trials Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) / TERAPEUTICA Year: 2007 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links